{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:49:25Z","timestamp":1793659765802,"version":"4.5.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Japan Agency for Medical Research and Development (AMED)","award":["H26-shinkou-jitsuyouka-007"],"award-info":[{"award-number":["H26-shinkou-jitsuyouka-007"]}]},{"name":"Japan Society for the Promotion of Science(JSPS)","award":["KAKENHI Grant-in-Aid for Young Scientists (B) 26870872"],"award-info":[{"award-number":["KAKENHI Grant-in-Aid for Young Scientists (B) 26870872"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1873-8","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T14:14:35Z","timestamp":1476800075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults"],"prefix":"10.1186","volume":"16","author":[{"given":"Yuka","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng Ling","family":"Moi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Kweng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kurane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"key":"1873_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496:504\u20137.","journal-title":"Nature"},{"issue":"3","key":"1873_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3201\/eid2103.141662","volume":"21","author":"S Kutsuna","year":"2015","unstructured":"Kutsuna S, Kato Y, Moi ML, Kotaki A, Ota M, Shinohara K, et al. Autochthonous dengue fever, Tokyo, Japan, 2014. Emerg Infect Dis. 2015;21(3):517\u201320.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"1873_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S1995-7645(14)60007-9","volume":"7","author":"KP Singh","year":"2014","unstructured":"Singh KP, Mishra G, Jain P, Pandey N, Nagar R, Gupta S, et al. Co-positivity of anti-dengue virus and anti-Japanese encephalitis virus IgM in endemic area: co-infection or cross reactivity? Asian Pac J Trop Med. 2014;7(2):124\u20139.","journal-title":"Asian Pac J Trop Med"},{"key":"1873_CR4","first-page":"175","volume":"7","author":"C Pipattanaboon","year":"2013","unstructured":"Pipattanaboon C, Sasaki T, Nishimura M, Setthapramote C, Pitaksajjakul P, Leaungwutiwong P, et al. Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus. Biologics. 2013;7:175\u201387.","journal-title":"Biologics"},{"issue":"Pt 12","key":"1873_CR5","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1099\/vir.0.031641-0","volume":"92","author":"KL Mansfield","year":"2011","unstructured":"Mansfield KL, Horton DL, Johnson N, Li L, Barrett AD, Smith DJ, et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol. 2011;92(Pt 12):2821\u20139.","journal-title":"J Gen Virol"},{"issue":"Pt 1","key":"1873_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","volume":"70","author":"CH Calisher","year":"1989","unstructured":"Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol. 1989;70(Pt 1):37\u201343.","journal-title":"J Gen Virol"},{"issue":"1","key":"1873_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jmv.21051","volume":"80","author":"Z Kou","year":"2008","unstructured":"Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, Schlesinger JJ, et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol. 2008;80(1):134\u201346.","journal-title":"J Med Virol"},{"issue":"8","key":"1873_CR8","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.144.8.3183","volume":"144","author":"R Littaua","year":"1990","unstructured":"Littaua R, Kurane I, Ennis FA. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol. 1990;144(8):3183\u20136.","journal-title":"J Immunol"},{"issue":"3","key":"1873_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3201\/eid0803.010238","volume":"8","author":"RB Tesh","year":"2002","unstructured":"Tesh RB, Travassos da Rosa AP, Guzman H, Araujo TP, Xiao SY. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis. 2002;8(3):245\u201351.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"1873_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4269\/ajtmh.2011.11-0012","volume":"84","author":"A Bosco-Lauth","year":"2011","unstructured":"Bosco-Lauth A, Mason G, Bowen R. Pathogenesis of Japanese encephalitis virus infection in a golden hamster model and evaluation of flavivirus cross-protective immunity. Am J Trop Med Hyg. 2011;84(5):727\u201332.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"1873_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1348-0421.1994.tb02152.x","volume":"38","author":"Y Makino","year":"1994","unstructured":"Makino Y, Tadano M, Saito M, Maneekarn N, Sittisombut N, Sirisanthana V, et al. Studies on serological cross-reaction in sequential flavivirus infections. Microbiol Immunol. 1994;38(12):951\u20135.","journal-title":"Microbiol Immunol"},{"issue":"10","key":"1873_CR12","doi-asserted-by":"publisher","first-page":"e1311","DOI":"10.1371\/journal.pntd.0001311","volume":"5","author":"KB Anderson","year":"2011","unstructured":"Anderson KB, Gibbons RV, Thomas SJ, Rothman AL, Nisalak A, Berkelman RL, et al. Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand. PLoS Negl Trop Dis. 2011;5(10):e1311.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"1873_CR13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4269\/ajtmh.1980.29.638","volume":"29","author":"SB Halstead","year":"1980","unstructured":"Halstead SB, Porterfield JS, O\u2019Rourke EJ. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg. 1980;29(4):638\u201342.","journal-title":"Am J Trop Med Hyg"},{"key":"1873_CR14","doi-asserted-by":"publisher","first-page":"19953","DOI":"10.1038\/srep19953","volume":"6","author":"J Li","year":"2016","unstructured":"Li J, Gao N, Fan D, Chen H, Sheng Z, Fu S, Liang G, et al. Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice. Sci Rep. 2016;6:19953.","journal-title":"Sci Rep"},{"issue":"2","key":"1873_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.2002.66.115","volume":"66","author":"N Kanesa-Thasan","year":"2002","unstructured":"Kanesa-Thasan N, Putnak JR, Mangiafico JA, Saluzzo JE, Ludwig GV. Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg. 2002;66(2):115\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"50","key":"1873_CR16","doi-asserted-by":"publisher","first-page":"7939","DOI":"10.1016\/j.vaccine.2010.09.076","volume":"28","author":"G Posadas-Herrera","year":"2010","unstructured":"Posadas-Herrera G, Inoue S, Fuke I, Muraki Y, Mapua CA, Khan AH, et al. Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate. Vaccine. 2010;28(50):7939\u201346.","journal-title":"Vaccine"},{"issue":"29","key":"1873_CR17","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","volume":"30","author":"FX Heinz","year":"2012","unstructured":"Heinz FX, Stiasny K. Flaviviruses and flavivirus vaccines. Vaccine. 2012;30(29):4301\u20136.","journal-title":"Vaccine"},{"issue":"3","key":"1873_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","volume":"23","author":"BA Coller","year":"2011","unstructured":"Coller BA, Clements DE. Dengue vaccines: progress and challenges. Curr Opin Immunol. 2011;23(3):391\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"1873_CR19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.vaccine.2014.01.040","volume":"32","author":"T Ishikawa","year":"2014","unstructured":"Ishikawa T, Yamanaka A, Konishi E. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine. 2014;32(12):1326\u201337.","journal-title":"Vaccine"},{"issue":"4","key":"1873_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jiac.2013.11.010","volume":"20","author":"N Takeshita","year":"2014","unstructured":"Takeshita N, Lim CK, Mizuno Y, Shimbo T, Kotaki A, Ujiie M, et al. Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults. J Infect Chemother. 2014;20(4):238\u201342.","journal-title":"J Infect Chemother"},{"issue":"10","key":"1873_CR21","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/infdis\/jir053","volume":"203","author":"ML Moi","year":"2011","unstructured":"Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Detection of higher levels of dengue viremia using Fc\u03b3R-expressing BHK-21 cells than Fc\u03b3R-negative cells in secondary infection but not in primary infection. J Infect Dis. 2011;203(10):1405\u201314.","journal-title":"J Infect Dis"},{"issue":"2","key":"1873_CR22","doi-asserted-by":"publisher","first-page":"e1536","DOI":"10.1371\/journal.pntd.0001536","volume":"6","author":"ML Moi","year":"2012","unstructured":"Moi ML, Lim CK, Chua KB, Takasaki T, Kurane I. Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using Fc\u03b3R-expressing cells. PLoS Negl Trop Dis. 2012;6(2):e1536.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1873_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/trstmh\/trs007","volume":"107","author":"ML Moi","year":"2013","unstructured":"Moi ML, Takasaki T, Saijo M, Kurane I. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection. Trans R Soc Trop Med Hyg. 2013;107(1):51\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1\u20132","key":"1873_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","volume":"221","author":"A Frey","year":"1998","unstructured":"Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods. 1998;221(1\u20132):35\u201341.","journal-title":"J Immunol Methods"},{"issue":"2","key":"1873_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jviromet.2009.10.026","volume":"163","author":"E Konishi","year":"2010","unstructured":"Konishi E, Tabuchi Y, Yamanaka A. A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells. J Virol Methods. 2010;163(2):360\u20137.","journal-title":"J Virol Methods"},{"issue":"1","key":"1873_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.146.1.201","volume":"146","author":"SB Halstead","year":"1977","unstructured":"Halstead SB, O\u2019Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977;146(1):201\u201317.","journal-title":"J Exp Med"},{"issue":"9","key":"1873_CR27","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.4049\/jimmunol.147.9.3139","volume":"147","author":"BJ Mady","year":"1991","unstructured":"Mady BJ, Erbe DV, Kurane I, Fanger MW, Ennis FA. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J Immunol. 1991;147(9):3139\u201344.","journal-title":"J Immunol"},{"issue":"Pt 1","key":"1873_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1099\/vir.0.014829-0","volume":"91","author":"ML Moi","year":"2010","unstructured":"Moi ML, Lim CK, Takasaki T, Kurane I. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J Gen Virol. 2010;91(Pt 1):103\u201311.","journal-title":"J Gen Virol"},{"issue":"20","key":"1873_CR29","doi-asserted-by":"publisher","first-page":"10128","DOI":"10.1128\/JVI.00792-06","volume":"80","author":"WW Rodrigo","year":"2006","unstructured":"Rodrigo WW, Jin X, Blackley SD, Rose RC, Schlesinger JJ. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). J Virol. 2006;80(20):10128\u201338.","journal-title":"J Virol"},{"issue":"1","key":"1873_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/JVI.02273-12","volume":"87","author":"JM Costin","year":"2013","unstructured":"Costin JM, Zaitseva E, Kahle KM, Nicholson CO, Rowe DK, Graham AS, et al. Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop. J Virol. 2013;87(1):52\u201366.","journal-title":"J Virol"},{"key":"1873_CR31","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1038\/ncomms7341","volume":"6","author":"G Fibriansah","year":"2015","unstructured":"Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, et al. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun. 2015;6:6341.","journal-title":"Nat Commun"},{"issue":"4","key":"1873_CR32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","volume":"40","author":"SC Kliks","year":"1989","unstructured":"Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989;40(4):444\u201351.","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"1873_CR33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1086\/340365","volume":"185","author":"DH Libraty","year":"2002","unstructured":"Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002;185(9):1213\u201321.","journal-title":"J Infect Dis"},{"issue":"3","key":"1873_CR34","doi-asserted-by":"publisher","first-page":"e0004497","DOI":"10.1371\/journal.pntd.0004497","volume":"10","author":"M Singla","year":"2016","unstructured":"Singla M, Kar M, Sethi T, Kabra SK, Lodha R, Chandele A, et al. Immune response to dengue virus infection in pediatric patients in New Delhi, India-Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity. PLoS Negl Trop Dis. 2016;10(3):e0004497.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"1873_CR35","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1056\/NEJM198809083191004","volume":"319","author":"CH Hoke","year":"1988","unstructured":"Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med. 1988;319(10):608\u201314.","journal-title":"N Engl J Med"},{"key":"1873_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2149\/tmh.2014-34","volume":"2","author":"R Sato","year":"2015","unstructured":"Sato R, Hamada N, Kashiwagi T, Imamura Y, Hara K, Naito Y, et al. Dengue hemorrhagic fever in a Japanese traveler who had preexisting Japanese encephalitis virus antibody. Trop Med Health. 2015;2:85\u20138.","journal-title":"Trop Med Health"},{"issue":"2","key":"1873_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/0974-777X.56257","volume":"1","author":"RO Izurieta","year":"2009","unstructured":"Izurieta RO, Macaluso M, Watts DM, Tesh RB, Guerra B, Cruz LM, et al. Anamnestic immune response to dengue and decreased severity of yellow fever. J Glob Infect Dis. 2009;1(2):111\u20136.","journal-title":"J Glob Infect Dis"},{"issue":"1","key":"1873_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.virol.2007.12.021","volume":"374","author":"CK Lim","year":"2008","unstructured":"Lim CK, Takasaki T, Kotaki A, Kurane I. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine. Virology. 2008;374(1):60\u201370.","journal-title":"Virology"},{"issue":"2","key":"1873_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0035-9203(02)90294-4","volume":"96","author":"DH Libraty","year":"2002","unstructured":"Libraty DH, Nisalak A, Endy TP, Suntayakorn S, Vaughn DW, Innis BL. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg. 2002;96(2):173\u20138.","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1873-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T14:01:04Z","timestamp":1692540064000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1873-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1873-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]},"article-number":"578"}}